Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2005 1
2007 1
2010 1
2012 1
2016 1
2018 2
2019 1
2020 4
2021 4
2022 1
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
A review of neovascular glaucoma. Etiopathogenesis and treatment.
Dumbrăveanu L, Cușnir V, Bobescu D. Dumbrăveanu L, et al. Rom J Ophthalmol. 2021 Oct-Dec;65(4):315-329. doi: 10.22336/rjo.2021.66. Rom J Ophthalmol. 2021. PMID: 35087972 Free PMC article. Review.
Thus, an early diagnosis, followed by starting an appropriate therapy: panretinal photocoagulation or administration of anti-VEGF drugs, with or without hypotensive ocular therapy, allows the preservation of visual functions for patient's better quality of life. How …
Thus, an early diagnosis, followed by starting an appropriate therapy: panretinal photocoagulation or administration of anti-VEGF dru …
Coats-like Exudative Vitreoretinopathy in Retinitis Pigmentosa: Ocular Manifestations and Treatment Outcomes.
Moinuddin O, Sathrasala S, Jayasundera KT, Branham KH, Chang EY, Qian CX, Recchia FM, Fahim AT, Besirli CG. Moinuddin O, et al. Ophthalmol Retina. 2021 Jan;5(1):86-96. doi: 10.1016/j.oret.2020.03.026. Epub 2020 Apr 9. Ophthalmol Retina. 2021. PMID: 32507488 Free PMC article.
PARTICIPANTS: Patients with a diagnosis of RP demonstrating Coats-like exudative vitreoretinopathy between January 1, 2008, and October 1, 2019. ...RESULTS: Nine patients diagnosed with RP and demonstrating Coats-like exudative vitreoretinopathy were i …
PARTICIPANTS: Patients with a diagnosis of RP demonstrating Coats-like exudative vitreoretinopathy between January 1, 2008, an …
Genotype-phenotype associations in familial exudative vitreoretinopathy: A systematic review and meta-analysis on more than 3200 individuals.
Wang X, Chen J, Xiong H, Yu X. Wang X, et al. PLoS One. 2022 Jul 13;17(7):e0271326. doi: 10.1371/journal.pone.0271326. eCollection 2022. PLoS One. 2022. PMID: 35830446 Free PMC article.
OBJECTIVE: To systematically review the relationship between genotypes and clinical phenotypes of Familial exudative vitreoretinopathy (FEVR) to support risk estimation and therapeutic decisions. ...Among all the cases, the mutation frequencies of LRP5, FZD4, …
OBJECTIVE: To systematically review the relationship between genotypes and clinical phenotypes of Familial exudative vitreoretinop …
INTRAVITREAL RANIBIZUMAB TREATMENT FOR ADVANCED FAMILIAL EXUDATIVE VITREORETINOPATHY WITH HIGH VASCULAR ACTIVITY.
Lyu J, Zhang Q, Xu Y, Zhang X, Fei P, Zhao P. Lyu J, et al. Retina. 2021 Sep 1;41(9):1976-1985. doi: 10.1097/IAE.0000000000003122. Retina. 2021. PMID: 34432746 Free PMC article.
PURPOSE: To determine the efficacy of intravitreal ranibizumab (IVR) treatment for advanced familial exudative vitreoretinopathy with high vascular activity. METHODS: The retrospective interventional case series included 28 eyes (20 patients) that had IVR in combina …
PURPOSE: To determine the efficacy of intravitreal ranibizumab (IVR) treatment for advanced familial exudative vitreoretinopathy …
EARLY-ONSET OF FAMILIAL EXUDATIVE VITREORETINOPATHY: Clinical Characteristics, Management, and Outcomes.
Kitic N, Chapron T, Metge-Galatoire F, Chehaibou I, Caputo G, Abdelmassih Y. Kitic N, et al. Retina. 2024 Apr 1;44(4):669-679. doi: 10.1097/IAE.0000000000004005. Retina. 2024. PMID: 37973048
PURPOSE: To describe the clinical characteristics, management, and outcomes of toddlers (under the age of 3) diagnosed with familial exudative vitreoretinopathy. METHODS: In this retrospective study, patients diagnosed with familial exudative vitreoretinop …
PURPOSE: To describe the clinical characteristics, management, and outcomes of toddlers (under the age of 3) diagnosed with familial exud …
LONG-TERM CLINICAL OUTCOMES AND GENOTYPE-PHENOTYPE CORRELATION IN FAMILIAL EXUDATIVE VITREORETINOPATHY IN A TERTIARY REFERRAL CENTER.
Tsai ASH, Kang EYC, Wang NK, Lee H, Seo GH, Khang R, Wu WC. Tsai ASH, et al. Retina. 2023 Nov 1;43(11):1945-1950. doi: 10.1097/IAE.0000000000003868. Retina. 2023. PMID: 37339455
BACKGROUND/PURPOSE: To evaluate clinical outcomes and assess genotype-phenotype correlations in patients with familial exudative vitreoretinopathy (FEVR). METHODS: Clinical charts of 40 patients with FEVR were reviewed. ...The mean age at diagnosis was 5.6 ye …
BACKGROUND/PURPOSE: To evaluate clinical outcomes and assess genotype-phenotype correlations in patients with familial exudative v …
Clinical features and treatment outcomes of vasoproliferative tumors in Indian participants.
Walinjkar JA, Sharma US, Rishi P, Rishi E, Gopal L, Sharma T. Walinjkar JA, et al. Indian J Ophthalmol. 2018 Feb;66(2):246-251. doi: 10.4103/ijo.IJO_210_17. Indian J Ophthalmol. 2018. PMID: 29380768 Free PMC article.
Most common association of secondary VPT was Coats disease followed by retinal vasculitis, polypoidal choroidal vasculopathy, familial exudative vitreoretinopathy, and traumatic chorioretinopathy. Ten tumors (45%) involved the inferior quadrant. Tumor-associated fea …
Most common association of secondary VPT was Coats disease followed by retinal vasculitis, polypoidal choroidal vasculopathy, familial ex …
Analysis of Predisposing Clinical Features for Worsening Traction After Treatment of Familial Exudative Vitreoretinopathy in Children.
Hubbard GB, Li AL. Hubbard GB, et al. Am J Ophthalmol. 2021 Mar;223:430-445. doi: 10.1016/j.ajo.2020.07.013. Epub 2020 Jul 21. Am J Ophthalmol. 2021. PMID: 32707203 Free PMC article.
PURPOSE: To determine the incidence of worsening vitreoretinal traction after laser treatment for familial exudative vitreoretinopathy (FEVR) and to determine whether any baseline clinical features are associated with worsening. ...At the 6-month follow-up, median l …
PURPOSE: To determine the incidence of worsening vitreoretinal traction after laser treatment for familial exudative vitreoretinop …
Novel variants in familial exudative vitreoretinopathy patients with KIF11 mutations and the Genotype-Phenotype correlation.
Chen C, Sun L, Li S, Huang L, Zhang T, Wang Z, Yu B, Luo X, Ding X. Chen C, et al. Exp Eye Res. 2020 Oct;199:108165. doi: 10.1016/j.exer.2020.108165. Epub 2020 Jul 28. Exp Eye Res. 2020. PMID: 32730767
Familial exudative vitreoretinopathy (FEVR) is an inherited disease characterized by abnormal development of retinal vasculature. ...Six of the probands were detected to have microcephaly. In conclusion: Most (5/9,55.6%) of the causative mutations were frames …
Familial exudative vitreoretinopathy (FEVR) is an inherited disease characterized by abnormal development of retinal vasculatu …
Clinical characteristics and surgical management of familial exudative vitreoretinopathy-associated rhegmatogenous retinal detachment.
Chen SN, Hwang JF, Lin CJ. Chen SN, et al. Retina. 2012 Feb;32(2):220-5. doi: 10.1097/IAE.0b013e31821c3ec5. Retina. 2012. PMID: 22277905
PURPOSE: The purpose of this study was to report the clinical characteristics and surgical outcome of familial exudative vitreoretinopathy-associated rhegmatogenous retinal detachment. METHODS: Retrospective interventional case series of patients with familial ex …
PURPOSE: The purpose of this study was to report the clinical characteristics and surgical outcome of familial exudative vitreoret …
19 results